{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:35:43Z","timestamp":1779237343512,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2001,8,1]]},"DOI":"10.1038\/sj.bmt.1703118","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T16:37:23Z","timestamp":1032280643000},"page":"243-249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Immune reconstitution following allogeneic stem cell transplantation in recipients conditioned by low intensity vs myeloablative regimen"],"prefix":"10.1038","volume":"28","author":[{"given":"S","family":"Morecki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Or","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Naparstek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Varadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Engelhard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Akerstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2001,9,4]]},"reference":[{"key":"BF1703118_CR1","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1002\/1097-0142(19820515)49:10<1963::AID-CNCR2820491004>3.0.CO;2-A","volume":"49","author":"ED Thomas","year":"1982","unstructured":"Thomas ED . Kettering Award lecture. The role of marrow transplantation in the eradication of malignant disease Cancer 1982 49: 1963\u20131969","journal-title":"Cancer"},{"key":"BF1703118_CR2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1182\/blood.V62.5.941.941","volume":"62","author":"RJ O'Reilly","year":"1983","unstructured":"O'Reilly RJ . Allogeneic bone marrow transplantation: current status and future directions Blood 1983 62: 941\u2013964","journal-title":"Blood"},{"key":"BF1703118_CR3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","volume":"75","author":"MM Horowitz","year":"1990","unstructured":"Horowitz MM, Gale RP, Sondel PM et al. Graft-versus-leukemia reactions after bone marrow transplantation Blood 1990 75: 555\u2013562","journal-title":"Blood"},{"key":"BF1703118_CR4","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1056\/NEJM199002153220701","volume":"322","author":"G Lucarelli","year":"1990","unstructured":"Lucarelli G, Galimberti M, Polci P et al. Bone marrow transplantation in patients with thalassemia New Engl J Med 1990 322: 417\u2013421","journal-title":"New Engl J Med"},{"key":"BF1703118_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/0305-7372(89)90018-2","volume":"16","author":"M Symann","year":"1989","unstructured":"Symann M, Bosly A, Gisselbrecht C et al. Immune reconstitution after bone marrow transplantation Cancer Treat Rev 1989 16: (Suppl. A) 15\u201319","journal-title":"Cancer Treat Rev"},{"key":"BF1703118_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1699-0463.1993.tb00136.x","volume":"101","author":"J Moller","year":"1993","unstructured":"Moller J, Hofmann B, Jacobsen N et al. Defective T-cell stimulatory pathways in patients after allogeneic bone marrow transplantation (BMT) in man APMIS 1993 101: 480\u2013486","journal-title":"APMIS"},{"key":"BF1703118_CR7","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1182\/blood.V85.4.1132.bloodjournal8541132","volume":"85","author":"J Kameoka","year":"1995","unstructured":"Kameoka J, Sato T, Torimoto Y et al. Differential CD26-mediated activation of the CD3 and CD2 pathways after CD6-depleted allogeneic bone marrow transplantation Blood 1995 85: 1132\u20131137","journal-title":"Blood"},{"key":"BF1703118_CR8","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1182\/blood.V88.6.2334.bloodjournal8862334","volume":"88","author":"C Pignata","year":"1996","unstructured":"Pignata C, Sanghera JS, Soiffer RJ et al. Defective activation of mitogen-activated protein kinase after allogeneic bone marrow transplantation Blood 1996 88: 2334\u20132341","journal-title":"Blood"},{"key":"BF1703118_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1097\/00007890-198202000-00008","volume":"33","author":"RP Witherspoon","year":"1982","unstructured":"Witherspoon RP, Kopecky K, Storb RF et al. Immunological recovery in 48 patients following syngeneic marrow transplantation for hematological malignancy Transplantation 1982 33: 143\u2013149","journal-title":"Transplantation"},{"key":"BF1703118_CR10","first-page":"2","volume":"21","author":"RP Witherspoon","year":"1984","unstructured":"Witherspoon RP, Lum LG, Storb R . Immunologic reconstitution after human marrow grafting Semin Hematol 1984 21: 2\u201310","journal-title":"Semin Hematol"},{"key":"BF1703118_CR11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1182\/blood.V91.3.756","volume":"91","author":"S Slavin","year":"1998","unstructured":"Slavin S, Nagler A, Naparstek E et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 1998 91: 756\u2013763","journal-title":"Blood"},{"key":"BF1703118_CR12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1182\/blood.V74.1.19.19","volume":"74","author":"MJ Keating","year":"1989","unstructured":"Keating MJ, Kantarjian H, Talpaz M et al. Fludarabine: a new agent with major activity against chronic lymphocytic leukemia Blood 1989 74: 19\u201325","journal-title":"Blood"},{"key":"BF1703118_CR13","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/S0140-6736(96)91681-5","volume":"347","author":"S Johnson","year":"1996","unstructured":"Johnson S, Smith AG, Loffler H et al. Multicentre prospective randomized trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL Lancet 1996 347: 1432\u20131438","journal-title":"Lancet"},{"key":"BF1703118_CR14","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/00001622-199409000-00005","volume":"6","author":"A Rohatiner","year":"1994","unstructured":"Rohatiner A, Lister TA . Management of follicular lymphoma Curr Opin Oncol 1994 6: 473\u2013479","journal-title":"Curr Opin Oncol"},{"key":"BF1703118_CR15","doi-asserted-by":"crossref","first-page":"4531","DOI":"10.1182\/blood.V89.12.4531","volume":"89","author":"S Giralt","year":"1997","unstructured":"Giralt S, Estey E, Albitar M et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy Blood 1997 89: 4531\u20134536","journal-title":"Blood"},{"key":"BF1703118_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3109\/00365516809076979","volume":"21","author":"A Boyum","year":"1968","unstructured":"Boyum A . Isolation of leukocytes from human blood Scand J Clin Lab Invest 1968 21: (Suppl. 97) 77\u201389","journal-title":"Scand J Clin Lab Invest"},{"key":"BF1703118_CR17","first-page":"269","volume":"7","author":"S Morecki","year":"1991","unstructured":"Morecki S, Nabet C, Ackerstein A et al. The effect of in vitro T lymphocyte depletion on generation of IL2-activated cytotoxic cells Bone Marrow Transplant 1991 7: 269\u2013273","journal-title":"Bone Marrow Transplant"},{"key":"BF1703118_CR18","first-page":"pp 102","volume-title":"Lecture Notes on Medical Statistics","author":"A Petrie","year":"1978","unstructured":"Petrie A . Linear regression and correlation In: Lecture Notes on Medical Statistics Blackwell: London 1978 pp 102\u2013128"},{"key":"BF1703118_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/BF01789019","volume":"35","author":"S Morecki","year":"1992","unstructured":"Morecki S, Revel-Vilk S, Nabet C et al. Immunological evaluation of patients with hematological malignancies receiving ambulatory cytokine-mediated immunotherapy with recombinant human interferon-\u03b12a and interleukin-2 Cancer Immunol Immunother 1992 35: 401\u2013411","journal-title":"Cancer Immunol Immunother"},{"key":"BF1703118_CR20","first-page":"55","volume":"52","author":"S Shiobara","year":"1989","unstructured":"Shiobara S, Ueda M, Harada M et al. Long-term observation of immunologic reconstitution after allogeneic bone marrow transplantation: differences in recovery among functional T cell subsets Nippon-Ketsueki-Gakkai-Zasshi 1989 52: 55\u201362","journal-title":"Nippon-Ketsueki-Gakkai-Zasshi"},{"key":"BF1703118_CR21","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1182\/blood.V75.10.2076.2076","volume":"75","author":"RJ Soiffer","year":"1990","unstructured":"Soiffer RJ, Bosserman L, Murray C et al. Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation Blood 1990 75: 2076\u20132084","journal-title":"Blood"},{"key":"BF1703118_CR22","first-page":"169","volume":"106","author":"C Parra","year":"1996","unstructured":"Parra C, Roldan E, Rodriguez C et al. Immunologic reconstitution of peripheral blood lymphocytes in patients treated by bone marrow transplantation Med Clin Barc 1996 106: 169\u2013173","journal-title":"Med Clin Barc"},{"key":"BF1703118_CR23","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/0145-2126(89)90092-1","volume":"13","author":"M Bengtsson","year":"1989","unstructured":"Bengtsson M, Smedmyr B, Festin R et al. B lymphocyte regeneration in marrow and blood after autologous bone marrow transplantation: increased numbers of B cells carrying activation and progression markers Leukemia Res 1989 13: 791\u2013797","journal-title":"Leukemia Res"},{"key":"BF1703118_CR24","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1111\/j.1365-2249.1990.tb03302.x","volume":"80","author":"SM Kelsey","year":"1990","unstructured":"Kelsey SM, Lowdell MW, Newland AC . IgG subclass levels and immune reconstitution after T cell-depleted allogeneic bone marrow transplantation Clin Exp Immunol 1990 80: 409\u2013412","journal-title":"Clin Exp Immunol"},{"key":"BF1703118_CR25","first-page":"339","volume":"8","author":"L Leino","year":"1991","unstructured":"Leino L, Lilius EM, Nikoskelainen J et al. The reappearance of 10 differentiation antigens on peripheral blood lymphocytes after allogeneic bone marrow transplantation Bone Marrow Transplant 1991 8: 339\u2013344","journal-title":"Bone Marrow Transplant"},{"key":"BF1703118_CR26","first-page":"7","volume":"11","author":"AB Foot","year":"1993","unstructured":"Foot AB, Potter MN, Donaldson C et al. Immune reconstitution after BMT in children Bone Marrow Transplant 1993 11: 7\u201313","journal-title":"Bone Marrow Transplant"},{"key":"BF1703118_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/sj.bmt.1701153","volume":"21","author":"MW Lowdell","year":"1998","unstructured":"Lowdell MW, Craston R, Ray N et al. The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia Bone Marrow Transplant 1998 21: 679\u2013686","journal-title":"Bone Marrow Transplant"},{"key":"BF1703118_CR28","first-page":"117","volume":"12","author":"EY Chan","year":"1994","unstructured":"Chan EY, Chiu EK, So MK et al. Peripheral blood lymphocyte subsets after allogeneic bone marrow transplantation: reconstitution and correlation with the occurrence of acute graft-versus-host disease Asian Pac J Allergy Immunol 1994 12: 117\u2013123","journal-title":"Asian Pac J Allergy Immunol"},{"key":"BF1703118_CR29","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3109\/08820139109050789","volume":"20","author":"A Lange","year":"1991","unstructured":"Lange A, Jazwiec B, Tomaszewska-Toporska B, Toporski J . Recovery of natural cytotoxicity after bone marrow transplantation Immunol Invest 1991 20: 207\u2013213","journal-title":"Immunol Invest"},{"key":"BF1703118_CR30","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/j.1365-2249.1994.tb06118.x","volume":"97","author":"P Comoli","year":"1994","unstructured":"Comoli P, Maccario R, Montagna D et al. Expression of p75 chain of IL-2 receptor in the early immunological reconstitution after allogeneic bone marrow transplantation Clin Exp Immunol 1994 97: 510\u2013516","journal-title":"Clin Exp Immunol"},{"key":"BF1703118_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1600-065X.1997.tb00981.x","volume":"157","author":"WJ Murphy","year":"1997","unstructured":"Murphy WJ, Longo DL . The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation Immunol Rev 1997 157: 167\u2013176","journal-title":"Immunol Rev"},{"key":"BF1703118_CR32","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1182\/blood.V71.5.1196.1196","volume":"71","author":"A Velardi","year":"1988","unstructured":"Velardi A, Terenzi A, Cucciaioni S et al. Imbalances within the peripheral blood T-helper (CD4+) and T-suppressor (CD8+) cell populations in the reconstitution phase after human bone marrow transplantation Blood 1988 71: 1196\u20131200","journal-title":"Blood"},{"key":"BF1703118_CR33","first-page":"187","volume":"13","author":"LG Lum","year":"1994","unstructured":"Lum LG, Joshi ID, Smith MR et al. Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intact Bone Marrow Transplant 1994 13: 187\u2013195","journal-title":"Bone Marrow Transplant"},{"key":"BF1703118_CR34","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1126\/science.785599","volume":"193","author":"S Slavin","year":"1976","unstructured":"Slavin S, Strober S, Fuks Z, Kaplan HS . Long-term survival of skin allografts in mice treated with fractionated total lymphoid irradiation Science 1976 193: 1252\u20131254","journal-title":"Science"},{"key":"BF1703118_CR35","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1084\/jem.146.1.34","volume":"146","author":"S Slavin","year":"1977","unstructured":"Slavin S, Strober S, Fuks Z, Kaplan HS . Induction of specific tissue transplantation tolerance using fractionated total lymphoid irradiation in adult mice. Long-term survival of allogeneic bone marrow and skin grafts J Exp Med 1977 146: 34\u201348","journal-title":"J Exp Med"},{"key":"BF1703118_CR36","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1084\/jem.147.3.700","volume":"147","author":"S Slavin","year":"1978","unstructured":"Slavin S, Reitz B, Bieber CP et al. Transplantation tolerance in adult rats using total lymphoid irradiation (TLI): permanent survival of skin, heart and marrow allografts J Exp Med 1978 147: 700\u2013707","journal-title":"J Exp Med"},{"key":"BF1703118_CR37","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/00007890-197911000-00001","volume":"28","author":"S Slavin","year":"1979","unstructured":"Slavin S, Fuks Z, Strober S et al. Overview: transplantation tolerance across major histocompatibility barriers after total lymphoid irradiation Transplantation 1979 28: 359\u2013361","journal-title":"Transplantation"},{"key":"BF1703118_CR38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/0167-5699(87)90852-8","volume":"8","author":"S Slavin","year":"1987","unstructured":"Slavin S . Total lymphoid irradiation (TLI) Immunol Today 1987 8: 88\u201392","journal-title":"Immunol Today"},{"key":"BF1703118_CR39","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1097\/00007890-199705270-00004","volume":"63","author":"T Prigozhina","year":"1997","unstructured":"Prigozhina T, Gurevitch O, Zhu J, Slavin S . Permanent and specific transplantation tolerance induced by a non-myeloablative treatment to a wide variety of allogeneic tissues Transplantation 1997 63: 1394\u20131399","journal-title":"Transplantation"},{"key":"BF1703118_CR40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/307168a0","volume":"307","author":"ST Ildstad","year":"1984","unstructured":"Ildstad ST, Sachs DH . Reconstitution with syngeneic plus allogeneic or xenogeneic bone marow leads to specific acceptance of allografts and xenografts Nature 1984 307: 168\u2013170","journal-title":"Nature"},{"key":"BF1703118_CR41","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1084\/jem.169.2.493","volume":"169","author":"Y Sharabi","year":"1989","unstructured":"Sharabi Y, Sachs DH . Mixed chimerism and permanent specific transplantation tolerance induced by a non-lethal preparative regimen J Exp Med 1989 169: 493\u2013502","journal-title":"J Exp Med"},{"key":"BF1703118_CR42","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nm0797-783","volume":"3","author":"M Sykes","year":"1997","unstructured":"Sykes M, Szot GL, Swenson KA, Pearson DA . Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning Nat Med 1997 3: 783\u2013787","journal-title":"Nat Med"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1703118","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1703118.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T22:20:06Z","timestamp":1648074006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1703118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8,1]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,8,1]]}},"alternative-id":["BF1703118"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1703118","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8,1]]},"assertion":[{"value":"6 November 2000","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2001","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2001","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}